ABVX ABIVAX: Earnings per share for the last twelve months

Official company branding of abivax.com (ABVX)

ABIVAX is implementing ESG standards in biotechnology by minimizing laboratory waste. Earnings per share over the last four quarters correlate with these processes, reaching a metric value of -6.13. Efficiency is maintained through strict control of component supplies. The primary growth catalyst will be the commercialization of obefazimod and the expansion of the immunology portfolio through partnerships with pharma behemoths.

Abivax (ABVX) - Net earnings per share (EPS TTM) from 02/21/2024 to 11/15/2026

Analytical breakdowns and data insights for company Abivax Corp (ABVX)

- current quotes and average value forecast:
Price Chart Abivax Corp|ABVX - Consensus Target
- company stock capitalization data:
Market Value Abivax Corp|ABVX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share Abivax|ABVX - Book Capitalization|Market Value to Book Value Ratio abivax.com|ABVX - Total Business Assets
- debt and liquidity data:
Total Debt to Capital ABIVAX|ABVX - Long-Term Liabilities to Capital|Short-Term Debt to Capital ABIVAX|ABVX - Company Aggregate Debts|Debts to Book Capitalization Abivax Pharma|ABVX - Company Long-Term Debt|Company Short-Term Debts Abivax|Quick Liquidity Indicator abivax.com
- earnings and valuation multiples indicators:
ABVX - Company Net Income|Projected Future Earnings ABIVAX|ABVX - P/E Multiple|Projected Price to Earnings Abivax Corp|ABVX - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Abivax S.A.|ABVX - Operating profit EBITDA|Net earnings per share (EPS TTM) Abivax|ABVX - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months abivax.com|ABVX - Earnings per share growth in current year|Expected earnings per share growth for next year ABIVAX
- sales and revenue data:
ABVX - Company Sales Volume|Company Projected Revenue Abivax S.A.|ABVX - Price-to-Sales Ratio|Forward P/S Multiple Abivax Corp|ABVX - Revenue Dynamics YoY (Last Twelve Months)
Analysis of all company metrics:Abivax SA (ABVX)
Manufactured products of Abivax Pharma

To minimize capital risks, an investor must track the issuer's ability to generate real equity income. This metric is calculated as the ratio of total annual net profit to the total number of shares, while the rolling annual earnings per share visualizes the margin stability of ABIVAX (ABVX) against the costs of laboratory certification and the complex logistics of clinical samples.

Competitor analysis for ABIVAX

ARGX - Earnings per share for the last twelve months|BioNTech Inc. (BNTX) - Net earnings per share for the last 12 months|ADMA Corp (ADMA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Protagonist Therapeutics|Net earnings per share for the last 12 months IMVT|Net earnings per share (EPS TTM) kiniksa.com|Earnings per share for the last twelve months Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CLDX (celldex.com)|Aurinia Pharma (AUPH) - Net earnings per one share for the last twelve months|BioCryst - Net earnings per share (EPS TTM)|VERA: Earnings per share for the last twelve months|DNTH: Net earnings per share (EPS TTM)|Pharvaris - Earnings per share for the trailing year|ABCL (AbCellera Bio) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Tourmaline|Net earnings per share (EPS TTM) PGEN|PHAR (pharming.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NKTR (nektar.com)|Upstream Bio (UPB) - Net earnings per one share for the last twelve months|ZBIO: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Immunome Bio|GOSS: Net earnings per share (EPS TTM)|KALV: Earnings per share for the last four quarters|SEPN (septerna.com) - Net earnings per share (EPS TTM)|Pieris Pharmaceuticals, Inc. - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Savara Inc. (SVRA)|Net earnings per share (EPS TTM) Rigel Corp (RIGL)|Earnings per share for the last twelve months AnaptysBio Inc ANAB|astriatx.com (ATXS) - Net earnings per one share for the last twelve months|enGene Bio - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RAPT|JBIO: Net earnings per share (EPS TTM)|Aclaris - Earnings per share for the trailing year|KYTX (Kyverna Therapeutics, Inc) - Net earnings per share (EPS TTM)|TLSA: Earnings per share for the trailing year|Net earnings per share for the last 12 months CABA (Cabaletta Bio)|VTYX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) THTX (Theratechnologies, Inc)|Earnings per share for the last four quarters AVTX (Avalo Therapeutics Inc.)|ELDN: Net earnings per share for the last 12 months|AGEN - Net earnings per share (EPS TTM)|Climb Bio Inc. (CLYM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZURA (Zura Bio)|Net earnings per share for the last 12 months ATYR|ADAG: Earnings per share for the trailing year|Net earnings per share (EPS TTM) IMA|Net earnings per share for the last four quarters Shattuck Therapeutics|Net earnings per share (EPS TTM) EQ (Equillium Inc)|Earnings per share for the last four quarters CNTB (Connect Pharma)|IMUX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters atarabio.com ATRA|IFRX: Net earnings per share (EPS TTM)|XFOR (X4 Pharmaceuticals, Inc) - Earnings per share for the last twelve months|Earnings per share for the last twelve months adicetbio.com|CELU: Earnings per share for the trailing year|Earnings per share for the last twelve months INmune Bio Corporation (INMB)|Net earnings per share for the last 12 months Barinthus Biotherapeutics Corp BRNS|Earnings per share for the last twelve months Kezar Life Sciences KZR|Earnings per share for the trailing year SABS|AKTX - Earnings per share for the last twelve months|Earnings per share for the trailing year ENLV (enlivex.com)|Q32 Bio Inc. (QTTB) - Earnings per share for the last twelve months|GeoVax Labs Inc - Earnings per share for the trailing year|EDSA (Edesa Biotech Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months IBIO|Earnings per share for the last twelve months Carisma Therapeutics Inc (CARM)|Net earnings per share (EPS TTM) XTL Biopharmaceuticals Ltd (XTLB)|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics Inc.)|Net earnings per share for the last four quarters HCW Biologics Inc. (HCWB)|Aptevo Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters aimimmuno.com AIM|ADTX (aditxt.com) - Net earnings per share for the last 12 months|GRI (GRI Bio) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Vyome Therapeutics|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last 12 months indaptusrx.com INDP|Net earnings per share (EPS TTM) SCNI (scinai.com)|Net earnings per share (EPS TTM) CalciMedica, Inc. CALI|AFMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Allakos Inc ALLK|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences Inc. (IGMS)|ITOS (iTeos Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocean Biomedical Inc OCEA|Earnings per share for the last twelve months TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio, Inc) - Earnings per share for the trailing year